Publications

The following is a partial listing of publications incorporating Mouse Specifics instrumentation, grouped according to category (Heart, Motor, Diet).  Some of these you can grab, others you might need to ask us for because of copyright laws.  Enjoy!

DIGIGAIT IMAGING SYSTEM
PUBLICATIONS

1. Amende I, Kale A, McCue S, Hampton MK, Hampton TG
Gait deterioration in the SOD1 G93A mouse model of ALS
Program No. 131.13. 2005 Abstract Viewer/Itinerary Planner. Washington, DC: Society for
Neuroscience, 2005. Online.

2. Hampton TG, Kale A, Gladstone K, Bridges J, Costa A, Amende I.
How to characterize gait dynamics in mouse models of neuromuscular disease.
Program No. 22.60. 2002 Abstract Viewer/Itinerary Planner. Washington, DC:
Society for Neuroscience, 2002. CD-ROM.

3. Hampton TG, Stasko MR, Kale A, Amende I, Costa A,
Gait dynamics in Trisomic mice: Quantitative Neurological Traits of Down Syndrome
Physiology & Behavior 82 (2004) 381– 389.

4. Huebsch KA, Kudryashova E, Wooley CM, Sher RB, Seburn KL, Spencer MJ, Cox GA
Mdm muscular dystrophy: interactions with calpain 3 and a novel functional role for titin’s N2A domain. Hum Mol Genet. 2005;14:2801-11.

5. Kale A, Amende I, Meyer GP, Crabbe JC, Hampton TG. Ethanol’s effects on gait
dynamics in mice investigated by ventral plane videography Alcohol Clin Exp Res. 2004;28:1839-
48.

6. Piskorski K, Kale A, Chu V, Otero JM, Gladstone K, Mueller P, Amende I, and Hampton
TG. Non-invasive physiology in conscious mice. 2002 Fourth World Congress
Alternatives Congress Trust Proceedings. 2004. ATLA 32, Supplement 1, 195–201,
2004.

7. Hampton TG, Kale A, McCue S, Glazier S, Hampton MK, Amende I. Gait deterioration in the
SOD1 G93A mouse model of ALS. Program No. 131.13. 2005 Abstract Viewer/Itinerary Planner.
Washington, DC: Society for Neuroscience, 2005. Online.

8. Kale A, Amende I, McCue S, Morgan J.P., Hampton TG
Early detection of gait abnormalities in the MPTP mouse model of Parkinson’s disease.
Movement Disorders, 2005 Congress Abstract Program.

9. Kale A, Amende I, McCue S, Glazier S, Morgan JP, Hampton TG.
Gait dynamics in mouse models of Parkinson’s disease and Huntington’s disease
J Neuroengineering Rehabil. 2005 Jul 25;2:20.

10. Li S, Kim JE, Budel S, Hampton TG, Strittmatter S. Transgenic inhibition of Nogo-66
receptor function allows axonal sprouting and improved locomotion after spinal injury.
Mol Cell Neurosci. 2005; 1:26-39.

11. Sharma N, Baxter MG, Petravicz J, Bragg DC, Schienda A, Standaert DG, Breakefield XO.
Impaired motor learning in mice expressing torsinA with the DYT1 dystonia mutation.
J Neurosci. 2005;25:5351-5.

12. Wooley CM, Sher RB, Kale A, Frankel WN, Cox GA, Seburn KL.
Gait analysis detects early changes in transgenic SOD1(G93A) mice.
Muscle Nerve. 2005; 32:43-50.

13. Hampton TG, Kale A, McCue S, Morgan JP, Amende I. Propranolol attenuates sympathetic
hyperfunction, delays motor dysfunction, and prolongs life in a mouse model of amyotrophic
lateral sclerosis. Eur Heart J, 27(Supp.):2161. 2006. 2006 [Online], P5469.

14. Hampton TG, Kale A, McCue S, Banville B, Farr SA, Amende I. See how they run: gait in blind
mice. Program No. 12.9. 2006 Abstract Viewer/Itinerary Planner. Atlanta, GA: Society for
Neuroscience, 2006.

15. Lee G, Cruz-Aguado R, Orban PC, Hampton TG, McCue S, Hayden MR, Shaw CA. Neurotoxic
susceptibility in a mouse model of ALS2 as revealed by behavioral analysis. Program No. 671.4.
2006 Abstract Viewer/Itinerary Planner. Atlanta, GA: Society for Neuroscience, 2006.

16. Piesla MJ, Leventhal L, Harrison JE, Strassle B, Cummons T, Rogers KE, Whiteside GT.
Neuropathic and inflammatory pain alters gait and constitutes a novel measurement of therapeutic
efficacy in the rat. Program No. 553.7. 2006 Abstract Viewer/Itinerary Planner. Atlanta, GA:
Society for Neuroscience, 2006.

17. Hampton TG, Kale A, Amende I, McCue S, Bhagavan HN, VanDongen C. (2007) Gait
disturbances in BIO 14.6 and BIO TO2 dystrophic hamsters. 2007 Experimental Biology meeting
abstracts [on CD-ROM], Abstract #558.3, 2007.

18. Hampton TG, VanDongen C, Amende I, Bhagavan HN, Kale A (2007). Does your mouse walk
strangely? Gait analysis in rodent models of neuromuscular disease. 2007 BIO International
Convention; meeting abstracts [Online], Abstract #4.

19. Theriault BR, Hampton TG, Amende I, Gomez CM. Gait analysis of mice emerging from isoflurane
anesthesia. 58th AALAS National Meeting, Accepted Abstract, 2007.

20. Vincelette J, Xu Y , Zhang L ,Schaefer CJ ,Vergona R , Sullivan ME , Hampton TG and Wang YX.
Gait analysis in a murine model of collagen-induced arthritis. 2007; Arthritis Research &
Therapy Volume 9 Issue 6.

21. Zinkhan, G. Paw print gait analysis in rats with spinal cord injury. [Doctoral Dissertation] Dallas (TX):
The University of Texas Southwestern Medical Center at Dallas; 2007.

22. A. Ganguly, M. Srinivas, A. Martinez, R. Mertz, D. Stevenson, A. O. Caggiano, M.P. Zimber.
Effects of acute chondroitinase treatment and training on functional recovery following moderate
spinal cord injury in rats. Program No. 405.6/TT10. 2007 Neuroscience Meeting Planner. San
Diego, CA: Society for Neuroscience, 2007. Online.

23. B. Luo, E. Lis, S. Na, I. J. Reynolds, A. G. DiLella. Neurturin protects against gait impairment and
induced unilateral neurodegeneration model. Program No. 265.3/T22. 200. Neuroscience Meeting
Planner. San Diego, CA: Society for Neuroscience, 2007. Online.

24. P. Rane, J. Shields, E. Ortiz, J. A. King. Emotional and cognitive deficits observed in early stages of
Parkinson’s disease. Program No. 445.1. 2007. Neuroscience Meeting Planner. San Diego, CA:
Society for Neuroscience, 2007. Online.

25. P. J. Huntington, G. Zinkhan, B. R. Botterman, K. E. Tansey. Hind limb locomotor recovery
following spinal cord injury in the rat: Comparison of automated paw print analysis at different gait
speeds, open field scores, and recovery time. Program No. 75.18/GG18. 2007 Neuroscience
Meeting Planner. San Diego, CA: Society for Neuroscience, 2007. Online.

26. Oien DB, Osterhaus GL, Latif SA, Pinkston JW, Fulks J, Johnson M, Fowler SC, Moskovitz
J. MsrA knockout mouse exhibits abnormal behavior and brain dopamine levels. Free Radic
Biol Med. 2008; 45:193-200.

27. Pallier PN, Drew CJG, Morton JA. The detection and measurement of
locomotor deficits in a transgenic mouse model of Huntington’s disease are task- and
protocol-dependent: Influence of non-motor factors on locomotor function. Brain Res Bull. 2009;
78:347-55.

28. Tabata RC, Chu TLH, Shaw CA: Genome British Columbia in Collaboration with the Student
Biotechnology Network Research Exchange. Stigmasterol glucoside is a putative
Neurotoxin: Behavioral and Neuropathological Evidence. 2008: Program 24.

29. Cabrera-Salazar MA, Roskelley EM, Bu J, Hodges BL, Yew N, Dodge JC, Shihabuddin LS, Sohar
S, Sleat DE, Scheule RK, Davidson BL, Cheng SH, Lobel P and Passini MA. Timing of Therapeutic
Intervention Determines Functional and Survival Outcomes in a Mouse Model of Late Infantile
Batten Disease. Molecular Therapy 2007; 10:1782–1788.

30. Rommelfanger KS, Edwards GL, Freeman KG, Liles LC, Miller GW, Weinshenker D.
Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice
Proc Natl Acad Sci U S A. 2007;104:13804-9.

31. Cashman, N.R., Chakrabartty, A, Rakhit, R. Osterman, JB.
METHODS AND COMPOSITIONS TO TREAT AND DETECT MISFOLDED-SOD1 MEDIATED
DISEASES WIPO Patent Application WO/2007/098607. 2008.

32. Rohe, MS. Role of SORLA in the brain and its relevance for Alzheimer disease
Dissertation to obtain the academic degree of Doctor of Natural Sciences (Dr. rer. Nat.)
Lodged in the Department of Biology, Chemistry, Pharmacy, Free University of Berlin
presented by Mr. Dipl.-Biol. Michael Stephen Rohe August 2008.

33. Cummings, CJ Shapiro, G Sankrithi, NS Chesworth, R. Method of treating neurological disorders
using clotrimazole and derivatives thereof. United States Patent Application 20070037800. 2008.

34. Callaway J.K., Habgood M., Ek C.J., Johansson P.A., Dziegielewska K. and Saunders N.R.
Pharmacology Dept, University of Melbourne, Parkville, Vic. 3010
Assessment of residual function and morphology after spinal cord contusion injury in rats:
behavioral and histological evidence; Australian Neuroscience Annual Meeting 2009.

35. Kim HA , O. Tuathaigh C , Waddington JL, Lawrence AJ, and Drago J. Motor impairments in a
mouse model of Huntington’s with selective ablation of D-1 Receptor- Expressing neurons in the
Striatum. Australian Neuroscience Annual Meeting 2009.

36. Dodge JC, Clarke J, Treleaven CM, Taksir TV, Griffiths DA,
Yang W, Fidler JA, Passini MA, Karey KP, Schuchman EH, Cheng SH, Shihabuddin LS.
Intracerebroventricular infusion of acid sphingomyelinase corrects
CNS manifestations in a mouse model of Niemann–Pick A disease. Experimental Neurology,
2009;215:349-357.

37. Crone SA, Zhong G, Harris-Warrick R , and Sharma K. In Mice Lacking V2a Interneurons, Gait
Depends on Speed of Locomotion. The Journal of Neuroscience 2009; 29:7098-7109.

38. Lubjuhn J, Gastens A, Wilpert G, Bargiotas P., Herrmann O, Murikinati S, Rabie T, Marti H, Amende I,
Hampton TG and Schwaninger M. Functional testing in a mouse stroke model induced by occlusion
of the distal middle cerebral artery Journal of Neuroscience Methods, 2009;
184:195-103.

39. Berryman ER., Harris RL, Moalli M, Bagi CM. Digigait™ quantitation of gait dynamics in rat
rheumatoid arthritis model. J Musculoskelet Neuronal Interact . 2009; 9:89-98.

40. Piesla MJ, Leventhal L, Strassle BW, Harrison JE, Cummons TA, Lu P, Whiteside GT
Abnormal gait, due to inflammation but not nerve injury, reflects enhanced nociception in
preclinical pain models. Brain Res. 2009; 1295:89-98.

41. Dai Y, Dudek NL, Li Q, Fowler SC, and Muma NA
Striatal Expression of a Calmodulin Fragment Improved Motor Function, Weight Loss, and
Neuropathology in the R6/2 Mouse Model of Huntington’s Disease. J Neuroscience, September 16,
2009 • 29(37):11550 –11559.

42. Springer JE, Ravikumar R, Lim HR, Cho SI, Moon GJ, Lee HY, Park EJ, Gwag BJ.
The Functional and Neuroprotective Actions of Neu2000, a Dual Acting Pharmacological Agent, in
the Treatment of Acute Spinal Cord Injury. J Neurotrauma. 2010 Jan;27(1):139-49.

43. Hampton TG, Amende I
Treadmill Gait Analysis Characterizes Gait Alterations in Parkinson’s Disease and Amyotrophic
Lateral Sclerosis Mouse Models. Journal of Motor Behavior, Vol. 42, No. 1, 2010.

44. Hurlock EC, Bose M, Pierce G, and Joho RH
Rescue of Motor Coordination by Purkinje Cell-Targeted Restoration of Kv3.3 Channels in Kcnc3-
Null Mice Requires Kcnc1. The Journal of Neuroscience, December 16, 2009 • 29(50):15735–
15744.

45. Ek CJ, Habgood MD, Callaway JK, Dennis R, Dziegielewska KM, Johansson PA, Potter A,
Wheaton B, Saunders NR
Spatio-temporal progression of grey and white matter damage following contusion injury in rat spinal
cord. PLoS One. 2010 Aug 9;5(8):e12021.

46. Xu YF, Gendron TF, Zhang YJ, Lin WL, D’Alton S, Sheng H, Casey MC, Tong J, Knight J, Yu
X, Rademakers R, Boylan K, Hutton M, McGowan E, Dickson DW, Lewis J, Petrucelli L.
Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation,
motor deficits, and early mortality in transgenic mice. J Neurosci. 2010 Aug 11; 30(32):10851-9.

47. Gómez-Sintes R, Lucas JJ
NFAT/Fas signaling mediates the neuronal apoptosis and motor side effects of GSK-3
inhibition in a mouse model of lithium therapy. J Clin Invest. 2010 Jul 1;120(7):2432-45. doi:
10.1172/JCI37873. Epub 2010 Jun 7.

48. Kravitz AV, Freeze BS, Parker PR, Kay K, Thwin MT, Deisseroth K, Kreitzer AC.
Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia
circuitry. Nature. 2010 Jul 29;466(7306):622-6. Epub 2010 Jul 7.

49. Hampton TG, Kale A, Amende I, Tang W, McCue S, Bhagavan HN, VanDongen CG
Gait Disturbances in Dystrophic Hamsters Journal of Biomedicine and Biotechnology
Volume 2011 (2011), Article ID 235354, 8 pages doi:10.1155/2011/235354

50. Goldberg N, Hampton TG, McCue S,Kale A, Meshul CK
Profiling Changes in Gait Dynamics Resulting From Progressive 1-Methyl-4-Phenyl-1,2,3,
6-Tetrahydropyridine-Induced Nigrostriatal Lesioning
Journal of Neuroscience Research 00:000–000 (2011)

51. Mancuso R, Oliván S, Osta R, Navarro X
Evolution of gait abnormalities in SOD1(G93A) transgenic mice.
Brain Res. 2011 Aug 11;1406:65-73. Epub 2011 Jul 5.

52. Gomez C., Bhattacharyya BJ, Hong L, Zhu H
Skeletal Muscle IP3R1 Receptors Amplify Physiological and Pathological Synaptic
Calcium Signals The Journal of Neuroscience, 26 October 2011, 31(43): 15269-15283

53. Glajch KE, Fleming SM, Surmeier DJ, Osten P
Sensorimotor assessment of the unilateral 6-hydroxydopamine mouse model of
Parkinson’s disease Behavioural Brain Research, 2012, in press

54. Puram SV,Riccio A, Koirala S, Ikeuchi Y,Kim AH, Corfas G, Bonni A
A TRPC5-regulated calcium signaling pathway controls dendrite patterning in the
mammalian brain Genes Dev. 2011 December 15; 25(24): 2659–2673.
doi: 10.1101/gad.174060.111 PMCID: PMC3248686

55. Gong P, Roseman J, Fernandez CG, Vetrivel KS, Bindokas VP, Zitzow LA,Kar S,
Parent AT and Thinakaran G
Transgenic neuronal overexpression reveals thatstringently regulated p23 expression
is critical for coordinated movement in mice Molecular Neurodegeneration 2011, 6:87

http://www.molecularneurodegeneration.com/content/6/1/87

56. Grace Lee Kam
Determination of disease progression with early toxin-induced neuropathology in
the aging mutant SOD mouse model of amyotrophic lateral sclerosis
A thesis submitted in partial fulfillment of the requirements for the degree of Doctor
of Philosophy in The Faculty of Graduate Studies (Experimental Medicine)
The University of British Columbia (Vancouver) December 2011

57. Gonzalez-Reyes LE, Verbitsky M, Blesa J, Jackson-Lewis V, Paredes D, Tillack K,
Phani S, Kramer ER, Przedborski S, Kottmann AH
Sonic Hedgehog Maintains Cellular and Neurochemical Homeostasis in the
Adult Nigrostriatal Circuit Neuron 75, 306–319, July 26, 2012 ª2012 Elsevier I

58. Hansen ST, Pulst SM
Response to ethanol induced ataxia between C57BL/6J and 129X1/SvJ
mouse strains using a treadmill based assay.
Pharmacol Biochem Behav. 2013 Jan;103(3):582-8. doi: 10.1016/j.pbb.2012.10.010.
Epub 2012 Oct 24.

59. Takano M, Komaki Y, Hikishima K, Konomi T, Fujiyoshi K, Tsuji O, Toyama Y,
Okano H, Nakamura M.
In vivo tracing of neural tracts in tiptoe walking Yoshimura mice by diffusion
tensor tractography. Spine (Phila Pa 1976). 2013 Jan 15;38(2):E66-72

 

 

ECGENIE SCREENING SYSTEM
PUBLICATIONS
1. Shioi T, Hampton TG, Douglas P, and Izumo S. Dominant negative p21ras
causes a progressive dilated cardiomyopathy in transgenic mice. Circulation, 1999; 100(18);I-52.

2. Amende I, Chu V, Morgan JP, and Hampton TG. Angiotensin II AT1
receptor blockade attenuates isoproterenol-induced cardiac hypertrophy in mice. Eur Heart J,
27(Supp.):2161. 2000.

3. Chu V, Otero JM, Lopez O, Morgan JP, Amende I, Hampton TG. Method for non-invasively
recording electrocardiograms in conscious mice. BioMedCentral Physiology 2001, 1(1):6.

4. Braun A, Trigatti BL, Post MJ, Sato K, Simons M, Edelberg JM, Rosenberg RD, Schrenzel M,
Krieger M. Loss of SR-BI Expression Leads to the Early Onset of Occlusive Atherosclerotic
Coronary Artery Disease, Spontaneous Myocardial Infarctions, Severe Cardiac Dysfunction, and
Premature Death in Apolipoprotein E. Deficient Mice. Circ Res 2002; 90: 270-276.

5. Chu V, Otero JM, Lopez O, Sullivan M, Morgan JP, Amende I, Hampton TG.
Electrocardiographic findings in mdx mice: a cardiac phenotype of Duchenne muscular
dystrophy. Muscle & Nerve 2002;513-519.

6. Min JY, Sullivan MF, Yan X, Feng X, Chu V, Wang JF, Amende I, Morgan JP, Philipson KD,
Hampton TG. Overexpression of Na+/Ca2+ exchanger gene attenuates postinfarction myocardial
dysfunction. Am J Physiol Heart Circ Physiol 2002 Dec;283(6):H2466-71.

7. Braun A, Zhang S, Miettinen HE, Ebrahim S, Holm TM, Vasile E, Post MJ, Yoerger DM, Picard
MH, Krieger JL, Andrews NC, Simons M, Krieger M. Probucol prevents early coronary heart
disease and death in the high-density lipoprotein receptor SR-BI/apolipoprotein-E double
knockout mouse. Proc Nat Acad Sci 2003; 100:7283-7288.

8. Sutliff RL, Haase C, Russ R, Hoit BD, Morris R, Norman AB, and Lewis W. Cocaine Increases
Mortality and Cardiac Mass in a Murine Transgenic Model of Acquired Immune Deficiency
Syndrome. Lab Invest ; 2003; 83: 983.

9. Svenson KL, Bogue MA, Peters LL. Invited review: Identifying new mouse models of
cardiovascular disease: a review of high-throughput screens of mutagenized and inbred strains. J
Appl Physiol 2003 94:1650-9.

10. Amende I, Dubach JM, Piskorski K, Morgan JP, and Hampton TG. ECG Monitoring and Analyses
in Mice. The Physiological Genomics of the Critically Ill Mouse in Basic Science for the
Cardiologist. 2004 pgs. 89-100.

11. Bachman E., Hampton TG, Dhillon H, Amende I,
Wang J., Morgan JP and Hollenberg AN – The Metabolic and Cardiovascular
Effects of Hyperthyroidism are Largely Independent of Beta-Adrenergic Stimulation
Endocrinology 2004;145:2767-74.

12. Lewis W, Miller Y, Haase C, Ludaway T, McNaught J, Russ R,
Steltzer J, Folpe A, Long R and Oshinski J – HIV viral protein R causes atrial cardiomyocyte
mitosis, mesenchymal tumor, dysrhythmia, and heart failure Lab Invest 2005; 85:182-92.

13. Maddatu TP, Garvey SM, Schroeder DG, Hampton TG, Cox GA. Transgenic rescue of
neurogenic atrophy in the nmd mouse reveals a role for Ighmbp2 in dilated cardiomyopathy.
Hum Mol Genet. 2004;13:1105-15.

14. Piskorksi K, Kale A, Chu V, Otero JM, Gladstone K, Mueller P, Amende I, and Hampton TG.
Non-invasive physiology in conscious mice. 2002 Fourth World Congress Alternatives Congress
Trust Proceedings. 2004, in press. ATLA 32, Supplement 1, 195–201, 2004.

15. Sanna MG, Liao J, Jo E, Alfonso C, Ahn M, Peterson MS, Webb B, Lefebvre S, Chun J, Gray N,
Rosen H; Sphingosine 1-Phosphate (S1P) Receptor Subtypes S1P1 and S1P3, Respectively,
Regulate Lymphocyte Recirculation and Heart Rate. The Journal of Biological Chemistry 2004;
279: 13839–13848.

16. Schuldt AJT, Hampton TG, Chu V, Vogler CA, Galvin N, Lessard ML, Barker JE. Cardiac
anomalies in beta-glucuronidase (GUSB) null mice are corrected by non-ablative neonatal
marrow transplantation. Proc Nat Acad Sci 2004; 101:603–608.

17. Sergey V. Ivanov, Jerrold M. Ward, Lino Tessarollo, Dorothea McAreavey, Vandana Sachdev,_
Lameh Fananapazir,_ Melissa K. Banks, Nicole Morris, Draginja Djurickovic, Deborah E. Devor-
Henneman, Ming-Hui Wei, Gregory W. Alvord, Boning Gao, James A. Richardson, John D. Minna,
Michael A. Rogawski, and Michael I. Lerman† – Cerebellar Ataxia, Seizures, Premature Death,
and Cardiac Abnormalities in Mice with Targeted Disruption of the Cacna2d2 Gene
American Journal of Pathology 2004; 165:1007-1018.

18. Lewis W, Haase CP, Miller YK, Ferguson B, Stuart T, Ludaway T, McNaught J, Russ R, Steltzer
J., Santoianni R, Long R, Fiermonte G, Palmieri F. Transgenic expression of the deoxynucleotide
carrier causes mitochondrial damage that is enhanced by NRTIs for AIDS. Lab Invest. 2005;
85:972-81.

19. Zhang S, Picard MH, Vasile E, Zhu Y, Raffai RL, Weisgraber KH, Krieger M.
Diet-induced-induced occlusive coronary atherosclerosis, myocardial infarction, cardiac
dysfunction, and premature death in scavenger receptor class B type I-deficient, hypomorphic
apolipoprotein ER61 mice. Circulation. 2005 111:3457-64.

20. Cho H, Park C. ,Hwang I, Han S, Schimel D, Despres D. and Kehrl JH
Rgs5 Targeting Leads to Chronic Low Blood Pressure and a Lean Body Habitus.
Molecular and Cellular Biology 2008, 28:2590–2597.

21. Hsiai, TK., Yu, H, Kim, ES, Ai, L
POLYMER-BASED CARDIOVASCULAR BIOSENSORS, MANUFACTURE, AND
USES THEREOF United States Patent Application 20080302675.

22. Non-invasively record ECGs in mice.
Arizona Branch AALAS Newsletter Vol. 22 No. 1 February 2009 p.13.

23. Isenberg JS, Qin Y, Maxhimer JB, Sipes JM, Despres D, Schnermann J, Frazier WA,
Roberts DD. Thrombospondin-1 and CD47 regulate blood pressure and cardiac responses to
vasoactive stress. Matrix Biol. 2009;28:110-9.

24. Shuqin Xing, Shirng-Wreng Tsaih, Rong Yuan, Karen L. Svenson, Linda M. Jorgenson, Milly So,
Beverly J. Paigen, and Ron Korstanje. Genetic influence on electrocardiogram time intervals and
heart rate in aging mice. Am J Physiol Heart Circ Physiol. 2009; 296:H1907-13.

25. Mabe AM and Hoover DB
Structural and functional cardiac cholinergic deficits in adult neurturin knockout mice
Cardiovascular Research 2009; 82:93–99.

26. Lachance D, Plante E, Bouchard-Thomassin A, Champetier S, Roussel E, Drolet MC, Couet J
and Arsenault M. Moderate Exercise Training Improves Survival and Ventricular Remodeling in
an Animal Model of Left Ventricular Volume Overload. Circ Heart Fail. 2009; 5:437-45.

27. Lynch KR, Macdonald TL
PHENYL-CYCLOALKYL AND PHENYL-HETEROCYCLIC DERIVATIVES AS S1P
RECEPTOR AGONISTS United States Patent Application 20090105315.

28. Heier CR, Hampton TG, Wang D, Didonato CJ.
Development of electrocardiogram intervals during growth of FVB/N neonate mice.
BMC Physiol. 2010 Aug 24;10:16.

29. Heier CR, Satta R, Lutz C, Didonato CJ.
Arrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice.
Hum Mol Genet. 2010 Aug 18. [Epub ahead of print].

Leave a Reply